If you come over to help, we've got your back
In the shadow of a returning Ebola outbreak, the Trump administration has chosen to quarantine American health workers not in the specialized biocontainment facilities built for this very purpose on US soil, but in a newly constructed fifty-bed unit at a Kenyan airbase — a decision that proceeds despite a court order attempting to block it. Former CDC leaders, infectious disease experts, and federal worker unions see in this choice not merely a logistical misstep, but a departure from the ethical compact that has long governed how democracies treat those who volunteer to stand between a pathogen and the public. The question being raised is not only whether the facility is adequate, but what kind of nation sends its healers abroad to recover, alone, when it has already built the rooms to bring them home.
- A fifty-bed quarantine facility is being constructed at Kenya's Laikipia airbase for American Ebola responders, even after Kenya's own high court moved to block it — and the first US personnel have already arrived.
- Former CDC director-level officials are writing to Congress in alarm, warning that this plan contradicts decades of ethical standards and ignores millions already spent on purpose-built US biocontainment infrastructure.
- Federal unions representing CDC workers say their members are being abandoned, left without clarity on whether quarantine is mandatory, whether they can return home, or who else the facility will serve.
- Infectious disease experts warn that isolating Americans in Kenya creates dangerous complications — from inadequate advanced care to the near-impossible logistics of treating an unrelated medical emergency far from home.
- Broader public health authorities caution that the policy's premise is flawed: travel restrictions have never reliably stopped disease spread, and withdrawing from international collaboration risks lasting damage to America's global health credibility.
The Trump administration is constructing a fifty-bed quarantine facility at Kenya's Laikipia airbase to house American health workers exposed to Ebola — a plan that has drawn swift and pointed condemnation from former US health officials, CDC unions, and infectious disease specialists who say it breaks sharply from both established protocol and ethical tradition.
The contrast with 2014 is striking. During the West African Ebola crisis, American responders were evacuated to specialized biocontainment units in Atlanta, Bethesda, Omaha, and New York, with no secondary transmission. Daniel Jernigan, who led the CDC's Ebola response during that outbreak after three decades at the agency, wrote to Congress that the new approach contradicts the ethical foundations that have guided every previous US response. He and others questioned why the administration would isolate workers in a foreign country when purpose-built domestic facilities already exist. Patients needing advanced care under the new plan would be flown to unidentified European hospitals.
Yolanda Jacobs of the AFGE Local 2883 union called it an abandonment of the workers on the ground — a departure from every prior administration's approach. Basic questions remain unanswered: whether quarantine applies to all Americans or only high-risk exposures, whether workers can choose to return home, and whether Kenyans and other responders would have access to the facility at all.
Ronald Nahass of the Infectious Diseases Society of America challenged the policy's core logic, noting that Americans could safely quarantine at home and that the US already possesses world-class Ebola treatment capacity. He raised a pointed practical concern: if a quarantined worker in Kenya suffered a heart attack or needed emergency surgery, the complexity of care would be vastly greater than in a domestic hospital. He also warned that Secretary Rubio's stated goal of preventing any Ebola cases from entering the US misreads the evidence — travel restrictions have historically failed to stop disease spread, while exposure monitoring and healthcare preparedness have proven effective.
For those who remember 2014, the symbolism cuts deep. The US then built a field hospital in West Africa open to health workers of all nationalities, sending a clear message of solidarity. The Kenya facility, critics say, sends the opposite signal — one that subordinates worker safety and public health science to political optics, and risks diminishing the global trust America has spent decades building.
The Trump administration is building a fifty-bed quarantine facility at Kenya's Laikipia airbase for American health workers exposed to Ebola, a decision that has triggered sharp criticism from former US health officials, CDC unions, and infectious disease experts who say it abandons established protocols and ethical standards.
The plan represents a stark reversal from how the US handled the 2014 West African Ebola outbreak, when American responders were safely evacuated to specialized biocontainment units in Atlanta, Bethesda, Omaha, and New York with no secondary transmission. Kenya's high court moved to block the facility, but the Kenyan and US governments proceeded anyway. The first American responders landed at the airbase on Saturday.
Daniel Jernigan, who spent three decades at the CDC and led the agency's Ebola response during the 2014 crisis, said in a letter to Congress that the new approach contradicts "so many ethical underpinnings that we have relied on for all of the past responses." He and other former health leaders questioned how current officials had arrived at a plan that isolates American workers in a foreign country when the US has already invested millions in purpose-built quarantine infrastructure staffed by world-class specialists. The facility in Kenya would offer medications and some respiratory support, but patients requiring advanced care would be flown to unidentified hospitals in Europe.
Yolanda Jacobs, president of the AFGE Local 2883 union representing CDC employees, called the plan an abandonment of workers responding to the outbreak, a departure from every previous administration's approach. The White House has not clarified whether the facility would serve Kenyans and other health workers involved in the response, whether all Americans would be required to quarantine or only those with high-risk exposures, or whether workers could choose to return home instead.
Ronald Nahass, president of the Infectious Diseases Society of America, argued that Americans could safely quarantine at home after exposure and that the US possesses some of the world's finest facilities for treating Ebola if symptoms developed. He questioned the logic of sending citizens abroad when domestic infrastructure exists specifically for this purpose. He also raised a practical concern: if an American in Kenya needed emergency care for an unrelated condition—a heart attack, appendicitis—the logistics would be far more complicated than treatment in a US hospital surrounded by specialists.
The experts also challenged the underlying premise of the policy. Secretary of State Marco Rubio has said the administration "cannot and will not allow any cases of Ebola to enter the United States," but Nahass noted that travel restrictions and border controls have historically proven ineffective at stopping disease spread. He emphasized that proven public health measures—monitoring exposures and ensuring healthcare providers are prepared—work far better than isolation policies. He also warned that stepping back from international collaboration and the World Health Organization platform would damage America's standing in global health and have lasting consequences.
The facility's creation marks a significant departure from the 2014 approach, when the US established a field hospital in West Africa explicitly to support health workers from all countries. Jernigan recalled the message then: "If you come over to west Africa to help, we've got your back." The new Kenya-only facility sends a different signal entirely—one that critics say prioritizes political messaging over worker safety and public health science.
Notable Quotes
This policy raises profound clinical, ethical, operational and legal concerns— Former US health officials in letter to Congress
We've spent taxpayer dollars to create some really first-class biocontainment units to specifically address this type of an issue. Why wouldn't you evacuate American citizens if you're concerned?— Ronald Nahass, president of the Infectious Diseases Society of America
The Hearth Conversation Another angle on the story
Why would the administration build a facility in Kenya when the US already has specialized units ready to go?
The stated reason is preventing Ebola from entering the country. But the experts point out that's not how disease containment actually works—you can't seal borders against infectious disease. The real shift seems to be ideological. Trump opposed bringing workers home in 2014, said they should "suffer the consequences." This facility lets him keep that position while still appearing to care for responders.
But doesn't Kenya have hospitals? Why is this unethical?
Kenya does, but that's not the point. The ethics issue is about abandoning your own people. For forty years, the US standard was: you go help, we bring you home to our best facilities if something goes wrong. That's how you get people willing to do dangerous work. This breaks that covenant. And it's Americans only—Kenyans and other international workers don't get the same protection.
What about the practical problems?
Several. A fifty-bed field hospital can't handle serious complications. If someone has a heart attack or needs surgery, what then? Send them to a Nairobi hospital in a bubble? Or back to the US anyway, defeating the whole purpose? The US already spent millions on biocontainment units with trained staff. Using them is cheaper and safer.
Does this actually stop Ebola from reaching America?
No. That's what the infectious disease experts keep saying. You can't keep viruses out with walls. What works is surveillance, preparedness, and transparency. Isolating American workers in Kenya doesn't accomplish any of that. It just signals distrust of your own healthcare system.
What's the international angle?
By stepping away from WHO coordination and global health collaboration, the US loses influence over how outbreaks are managed. Other countries notice. It weakens America's ability to lead on the next crisis. And it sends a message that we're not reliable partners—which makes international cooperation harder when you actually need it.